Eupraxia Pharmaceuticals Inc. financial data

Symbol
EPRX on Nasdaq
Location
201 2067 Cadboro Bay Rd., Victoria, British Columbia, Canada
Fiscal year end
December 31
Latest financial report
40-F - Q4 2023 - Apr 1, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 27.3M shares
Common Stock, Shares, Outstanding 27.3M shares +26.3%
Common Stock, Value, Issued 92.9M USD +30.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 19.3M USD +5.91%
Assets, Current 19.8M USD +6.53%
Property, Plant and Equipment, Net 410K USD -7.64%
Operating Lease, Right-of-Use Asset 46.7K USD -46.5%
Assets 20.3M USD +5.98%
Accounts Payable, Current 1.29M USD -28.8%
Liabilities, Current 19.4M USD +533%
Liabilities 19.4M USD +62.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.71M USD +2.86%
Retained Earnings (Accumulated Deficit) -106M USD -36.5%
Stockholders' Equity Attributable to Parent 2.22M USD -71.5%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 892K USD -87.6%
Liabilities and Equity 20.3M USD +5.98%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares, Issued 27.3M shares +26.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 19.3M USD +5.91%
Deferred Tax Assets, Valuation Allowance 26.7M USD +55.5%
Operating Lease, Liability 53.3K USD -47.6%
Lessee, Operating Lease, Liability, to be Paid 60.8K USD
Property, Plant and Equipment, Gross 808K USD +9.69%
Operating Lease, Liability, Current 53.3K USD +5.78%
Lessee, Operating Lease, Liability, to be Paid, Year One 60.8K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.14 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 7.46K USD
Deferred Tax Assets, Operating Loss Carryforwards 18.3M USD +43.6%
Deferred Tax Assets, Net of Valuation Allowance 0 USD